. 2017 Mar 20;11:901–908. doi: 10.2147/DDDT.S131316

Table 2.

Changes in the level of urinary glucose and protein after treatment with CDDP, NAC, and TAU both individually and in combination

Groups	Urinary glucose, mg/dL	Urinary protein, mg/dL
Control	7.12^a±0.43	0.75^a±0.06
NAC	6.50^a±0.60	0.91^a±0.04
TAU	7.33^a±0.54	1.02^a±0.05
NAC–TAU	6.71^a±0.66	0.90^a±0.05
CDDP	46.80^c±3.93	5.70^c±0.26
CDDP–NAC	19.71^b±1.23	2.21^b±0.18
CDDP–TAU	26.20^d±2.59	2.60^b±0.15
CDDP–NAC–TAU	11.20^a,b±0.97	1.03^a±0.08

Notes: Each value represents the mean ± standard error for each experimental group (n=6). Mean values within the same column not sharing a common superscript (a–d) are significantly different (P≤0.05).

Abbreviations: CDDP, cisplatin; NAC, N-acetylcysteine; TAU, taurine.